Telangana Pharma Factory Blast: Death Toll Climbs to 35; DNA Identification Ongoing at Patancheru Hospital

The Telangana pharma unit blast in Sangareddy district has left the state in mourning, with the death toll rising to 35 as rescue operations continue. The explosion at a pharmaceutical facility in the Pashamylaram industrial area is now considered one of the deadliest in recent years, prompting national concern and urgent investigation.

Rising Death Toll and Ongoing Rescue Operations

Rescue workers recovered more bodies from the debris late last night, pushing the Sangareddy factory death toll to 35. The impact of the explosion was so intense that many victims could only be identified through DNA matching, which is currently being carried out at Patancheru hospital. The intensity of the blast led to severe burn injuries, making visual identification nearly impossible, said a senior medical official. We are working with families to expedite DNA tests for accurate identification and closure.

State Government’s Response

Chief Minister Revanth Reddy has announced compensation for the victims families and assured strict action against any lapses in safety compliance. A special investigation team has been deployed to assess regulatory violations at the site. The Telangana death toll has reignited discussions on the enforcement of industrial safety norms in the rapidly growing pharmaceutical corridor of the state.

Focus on Industrial Safety

The Sangareddy factory blast is the latest in a series of industrial accidents in Telangana. It has raised serious concerns about compliance with safety protocols in high-risk zones. Industry experts are now calling for more stringent inspections and mandatory disaster response training for workers. The pharma industry is a cornerstone of Telangana’s economy, but tragedies like this underline the urgent need for stronger safety regulations, said a Hyderabad-based industrial safety consultant.

A Tragic Wake-Up Call for Industrial Safety Reform

As the community mourns the rising Telangana death toll, the incident serves as a grim reminder of the price paid for negligence in industrial safety. The ongoing DNA identification at Patancheru hospital will help bring closure to grieving families, but systemic reforms will be key to preventing such disasters in the future. As the Sangareddy factory death toll climbs and families await DNA identification at Patancheru hospital, the tragedy highlights glaring gaps in regulatory oversight. Beyond compensation and political assurances, this incident must serve as a turning point, prompting tighter enforcement, periodic audits, and better preparedness in Telangana’s booming industrial zones.